<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1998-12-15" modified="2020-10-07" version="207">
<accession>O14773</accession>
<accession>Q53HT1</accession>
<accession>Q5JAK6</accession>
<accession>Q6UX56</accession>
<accession>Q71JP6</accession>
<accession>Q96C37</accession>
<name>TPP1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Tripeptidyl-peptidase 1</fullName>
<shortName>TPP-1</shortName>
<ecNumber evidence="6 18 19">3.4.14.9</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Cell growth-inhibiting gene 1 protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Lysosomal pepstatin-insensitive protease</fullName>
<shortName>LPIC</shortName>
</alternativeName>
<alternativeName>
<fullName>Tripeptidyl aminopeptidase</fullName>
</alternativeName>
<alternativeName>
<fullName>Tripeptidyl-peptidase I</fullName>
<shortName>TPP-I</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">TPP1</name>
<name type="synonym">CLN2</name>
<name type="ORF">GIG1</name>
<name type="ORF">UNQ267/PRO304</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="Science" volume="277" first="1802" last="1805">
<title>Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis.</title>
<authorList>
<person name="Sleat D.E."/>
<person name="Donnelly R.J."/>
<person name="Lackland H."/>
<person name="Liu C.-G."/>
<person name="Sohar I."/>
<person name="Pullarkat R.K."/>
<person name="Lobel P."/>
</authorList>
<dbReference type="PubMed" id="9295267"/>
<dbReference type="DOI" id="10.1126/science.277.5333.1802"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>VARIANTS CLN2 ARG-365 AND TYR-365</scope>
<scope>VARIANT HIS-175</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1998" name="Genomics" volume="50" first="206" last="212">
<title>Structural organization and sequence of CLN2, the defective gene in classical late infantile neuronal ceroid lipofuscinosis.</title>
<authorList>
<person name="Liu C.-G."/>
<person name="Sleat D.E."/>
<person name="Donnelly R.J."/>
<person name="Lobel P."/>
</authorList>
<dbReference type="PubMed" id="9653647"/>
<dbReference type="DOI" id="10.1006/geno.1998.5328"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2002-03" db="EMBL/GenBank/DDBJ databases">
<title>Bovine brain homolog of the tripeptidyl peptidase I which is deficient in the human classic late-infantile neuronal ceroid lipofuscinosis.</title>
<authorList>
<person name="Junaid M.A."/>
<person name="Barua M."/>
<person name="Pullarkat R.K."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain cortex</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="2003-04" db="EMBL/GenBank/DDBJ databases">
<title>Identification of a human growth inhibition gene 1 (GIG1).</title>
<authorList>
<person name="Kim J.W."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2003" name="Genome Res." volume="13" first="2265" last="2270">
<title>The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.</title>
<authorList>
<person name="Clark H.F."/>
<person name="Gurney A.L."/>
<person name="Abaya E."/>
<person name="Baker K."/>
<person name="Baldwin D.T."/>
<person name="Brush J."/>
<person name="Chen J."/>
<person name="Chow B."/>
<person name="Chui C."/>
<person name="Crowley C."/>
<person name="Currell B."/>
<person name="Deuel B."/>
<person name="Dowd P."/>
<person name="Eaton D."/>
<person name="Foster J.S."/>
<person name="Grimaldi C."/>
<person name="Gu Q."/>
<person name="Hass P.E."/>
<person name="Heldens S."/>
<person name="Huang A."/>
<person name="Kim H.S."/>
<person name="Klimowski L."/>
<person name="Jin Y."/>
<person name="Johnson S."/>
<person name="Lee J."/>
<person name="Lewis L."/>
<person name="Liao D."/>
<person name="Mark M.R."/>
<person name="Robbie E."/>
<person name="Sanchez C."/>
<person name="Schoenfeld J."/>
<person name="Seshagiri S."/>
<person name="Simmons L."/>
<person name="Singh J."/>
<person name="Smith V."/>
<person name="Stinson J."/>
<person name="Vagts A."/>
<person name="Vandlen R.L."/>
<person name="Watanabe C."/>
<person name="Wieand D."/>
<person name="Woods K."/>
<person name="Xie M.-H."/>
<person name="Yansura D.G."/>
<person name="Yi S."/>
<person name="Yu G."/>
<person name="Yuan J."/>
<person name="Zhang M."/>
<person name="Zhang Z."/>
<person name="Goddard A.D."/>
<person name="Wood W.I."/>
<person name="Godowski P.J."/>
<person name="Gray A.M."/>
</authorList>
<dbReference type="PubMed" id="12975309"/>
<dbReference type="DOI" id="10.1101/gr.1293003"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Suzuki Y."/>
<person name="Sugano S."/>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Adipose tissue</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Lymph</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="2249" last="2255">
<title>The human CLN2 protein/tripeptidyl-peptidase I is a serine protease that autoactivates at acidic pH.</title>
<authorList>
<person name="Lin L."/>
<person name="Sohar I."/>
<person name="Lackland H."/>
<person name="Lobel P."/>
</authorList>
<dbReference type="PubMed" id="11054422"/>
<dbReference type="DOI" id="10.1074/jbc.m008562200"/>
</citation>
<scope>PROTEIN SEQUENCE OF 20-24; 196-200 AND 466-492</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>PROTEOLYTIC CLEAVAGE</scope>
<scope>MUTAGENESIS OF HIS-236; ASP-360; SER-475 AND ASP-517</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2003" name="J. Proteome Res." volume="2" first="69" last="79">
<title>Proteomic analysis of early melanosomes: identification of novel melanosomal proteins.</title>
<authorList>
<person name="Basrur V."/>
<person name="Yang F."/>
<person name="Kushimoto T."/>
<person name="Higashimoto Y."/>
<person name="Yasumoto K."/>
<person name="Valencia J."/>
<person name="Muller J."/>
<person name="Vieira W.D."/>
<person name="Watabe H."/>
<person name="Shabanowitz J."/>
<person name="Hearing V.J."/>
<person name="Hunt D.F."/>
<person name="Appella E."/>
</authorList>
<dbReference type="PubMed" id="12643545"/>
<dbReference type="DOI" id="10.1021/pr025562r"/>
</citation>
<scope>SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Melanoma</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="Nat. Biotechnol." volume="21" first="660" last="666">
<title>Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry.</title>
<authorList>
<person name="Zhang H."/>
<person name="Li X.-J."/>
<person name="Martin D.B."/>
<person name="Aebersold R."/>
</authorList>
<dbReference type="PubMed" id="12754519"/>
<dbReference type="DOI" id="10.1038/nbt827"/>
</citation>
<scope>GLYCOSYLATION AT ASN-443</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="Hum. Mutat." volume="14" first="199" last="215">
<title>Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5.</title>
<authorList>
<person name="Mole S.E."/>
<person name="Mitchison H.M."/>
<person name="Munroe P.B."/>
</authorList>
<dbReference type="PubMed" id="10477428"/>
<dbReference type="DOI" id="10.1002/(sici)1098-1004(1999)14:3&lt;199::aid-humu3&gt;3.0.co;2-a"/>
</citation>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2006" name="J. Proteome Res." volume="5" first="3135" last="3144">
<title>Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes.</title>
<authorList>
<person name="Chi A."/>
<person name="Valencia J.C."/>
<person name="Hu Z.-Z."/>
<person name="Watabe H."/>
<person name="Yamaguchi H."/>
<person name="Mangini N.J."/>
<person name="Huang H."/>
<person name="Canfield V.A."/>
<person name="Cheng K.C."/>
<person name="Yang F."/>
<person name="Abe R."/>
<person name="Yamagishi S."/>
<person name="Shabanowitz J."/>
<person name="Hearing V.J."/>
<person name="Wu C."/>
<person name="Appella E."/>
<person name="Hunt D.F."/>
</authorList>
<dbReference type="PubMed" id="17081065"/>
<dbReference type="DOI" id="10.1021/pr060363j"/>
</citation>
<scope>SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Melanoma</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2007" name="Pediatr. Res." volume="61" first="146" last="152">
<title>Neuronal ceroid lipofuscinosis: a common pathway?</title>
<authorList>
<person name="Persaud-Sawin D.A."/>
<person name="Mousallem T."/>
<person name="Wang C."/>
<person name="Zucker A."/>
<person name="Kominami E."/>
<person name="Boustany R.M."/>
</authorList>
<dbReference type="PubMed" id="17237713"/>
<dbReference type="DOI" id="10.1203/pdr.0b013e31802d8a4a"/>
</citation>
<scope>INTERACTION WITH CLN3</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="BMC Cell Biol." volume="10" first="83" last="83">
<title>Novel interactions of CLN5 support molecular networking between neuronal ceroid lipofuscinosis proteins.</title>
<authorList>
<person name="Lyly A."/>
<person name="von Schantz C."/>
<person name="Heine C."/>
<person name="Schmiedt M.L."/>
<person name="Sipilae T."/>
<person name="Jalanko A."/>
<person name="Kyttaelae A."/>
</authorList>
<dbReference type="PubMed" id="19941651"/>
<dbReference type="DOI" id="10.1186/1471-2121-10-83"/>
</citation>
<scope>INTERACTION WITH CLN5</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-210; ASN-222; ASN-313 AND ASN-443</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>CLEAVAGE OF PROPEPTIDE [LARGE SCALE ANALYSIS] AFTER GLY-195</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="3976" last="3984">
<title>Structure of tripeptidyl-peptidase I provides insight into the molecular basis of late infantile neuronal ceroid lipofuscinosis.</title>
<authorList>
<person name="Pal A."/>
<person name="Kraetzner R."/>
<person name="Gruene T."/>
<person name="Grapp M."/>
<person name="Schreiber K."/>
<person name="Gronborg M."/>
<person name="Urlaub H."/>
<person name="Becker S."/>
<person name="Asif A.R."/>
<person name="Gartner J."/>
<person name="Sheldrick G.M."/>
<person name="Steinfeld R."/>
</authorList>
<dbReference type="PubMed" id="19038966"/>
<dbReference type="DOI" id="10.1074/jbc.m806947200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS)</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PROTEOLYTIC CLEAVAGE</scope>
<scope>ACTIVE SITE</scope>
<scope>CALCIUM-BINDING SITES</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-210; ASN-286; ASN-313 AND ASN-443</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="3985" last="3997">
<title>Crystal structure and autoactivation pathway of the precursor form of human tripeptidyl-peptidase 1, the enzyme deficient in late infantile ceroid lipofuscinosis.</title>
<authorList>
<person name="Guhaniyogi J."/>
<person name="Sohar I."/>
<person name="Das K."/>
<person name="Stock A.M."/>
<person name="Lobel P."/>
</authorList>
<dbReference type="PubMed" id="19038967"/>
<dbReference type="DOI" id="10.1074/jbc.m806943200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 20-563</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVE SITE</scope>
<scope>DISULFIDE BONDS</scope>
<scope>CALCIUM-BINDING SITES</scope>
<scope>SUBUNIT</scope>
<scope>AUTOPROTEOLYTIC CLEAVAGE</scope>
<scope>GLYCOSYLATION AT ASN-210; ASN-286; ASN-313 AND ASN-443</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1999" name="Am. J. Hum. Genet." volume="64" first="1511" last="1523">
<title>Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder.</title>
<authorList>
<person name="Sleat D.E."/>
<person name="Gin R.M."/>
<person name="Sohar I."/>
<person name="Wisniewski K."/>
<person name="Sklower-Brooks S."/>
<person name="Pullarkat R.K."/>
<person name="Palmer D.N."/>
<person name="Lerner T.J."/>
<person name="Boustany R.-M.N."/>
<person name="Uldall P."/>
<person name="Siakotos A.N."/>
<person name="Donnelly R.J."/>
<person name="Lobel P."/>
</authorList>
<dbReference type="PubMed" id="10330339"/>
<dbReference type="DOI" id="10.1086/302427"/>
</citation>
<scope>VARIANTS CLN2 ARG-77; ASN-287; LYS-343; ARG-365; TYR-365; ASP-385; GLU-389; HIS-422; HIS-447; GLU-454 AND LEU-475</scope>
<scope>VARIANT ARG-100</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2000" name="Ann. Neurol." volume="47" first="254" last="257">
<title>Prenatal testing for late infantile neuronal ceroid lipofuscinosis.</title>
<authorList>
<person name="Berry-Kravis E."/>
<person name="Sleat D.E."/>
<person name="Sohar I."/>
<person name="Meyer P."/>
<person name="Donnelly R."/>
<person name="Lobel P."/>
</authorList>
<dbReference type="PubMed" id="10665500"/>
<dbReference type="DOI" id="10.1002/1531-8249(200002)47:2&lt;254::aid-ana19&gt;3.0.co;2-7"/>
</citation>
<scope>VARIANT CLN2 CYS-206</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2000" name="Genet. Med." volume="2" first="312" last="318">
<title>Heterogeneity of late-infantile neuronal ceroid lipofuscinosis.</title>
<authorList>
<person name="Zhong N."/>
<person name="Moroziewicz D.N."/>
<person name="Ju W."/>
<person name="Jurkiewicz A."/>
<person name="Johnston L."/>
<person name="Wisniewski K.E."/>
<person name="Brown W.T."/>
</authorList>
<dbReference type="PubMed" id="11339651"/>
<dbReference type="DOI" id="10.109700125817-200011000-00002"/>
</citation>
<scope>VARIANTS CLN2 GLN-127; VAL-284; ASN-428 AND ARG-473</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2001" name="Am. J. Med. Genet." volume="99" first="161" last="163">
<title>Two novel CLN2 gene mutations in a Chinese patient with classical late-infantile neuronal ceroid lipofuscinosis.</title>
<authorList>
<person name="Lam C.W."/>
<person name="Poon P.M."/>
<person name="Tong S.F."/>
<person name="Ko C.H."/>
</authorList>
<dbReference type="PubMed" id="11241479"/>
<dbReference type="DOI" id="10.1002/1096-8628(2001)9999:9999&lt;::aid-ajmg1145&gt;3.0.co;2-z"/>
</citation>
<scope>VARIANT CLN2 ARG-473</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2001" name="Eur. J. Paediatr. Neurol." volume="5" first="7" last="10">
<title>New mutations in the neuronal ceroid lipofuscinosis genes.</title>
<authorList>
<person name="Mole S.E."/>
<person name="Zhong N.A."/>
<person name="Sarpong A."/>
<person name="Logan W.P."/>
<person name="Hofmann S."/>
<person name="Yi W."/>
<person name="Franken P.F."/>
<person name="van Diggelen O.P."/>
<person name="Breuning M.H."/>
<person name="Moroziewicz D."/>
<person name="Ju W."/>
<person name="Salonen T."/>
<person name="Holmberg V."/>
<person name="Jaervelae I."/>
<person name="Taschner P.E.M."/>
</authorList>
<dbReference type="PubMed" id="11589012"/>
<dbReference type="DOI" id="10.1053/ejpn.2000.0427"/>
</citation>
<scope>VARIANT CLN2 LEU-202</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2001" name="Hum. Mutat." volume="18" first="165" last="165">
<title>Expression and analysis of CLN2 variants in CHO cells: Q100R represents a polymorphism, and G389E and R447H represent loss-of-function mutations.</title>
<authorList>
<person name="Lin L."/>
<person name="Lobel P."/>
</authorList>
<dbReference type="PubMed" id="11462245"/>
<dbReference type="DOI" id="10.1002/humu.1170"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS ARG-100; GLU-389 AND HIS-447</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2002" name="Am. J. Med. Genet." volume="112" first="347" last="354">
<title>Late infantile neuronal ceroid lipofuscinosis: quantitative description of the clinical course in patients with CLN2 mutations.</title>
<authorList>
<person name="Steinfeld R."/>
<person name="Heim P."/>
<person name="von Gregory H."/>
<person name="Meyer K."/>
<person name="Ullrich K."/>
<person name="Goebel H.H."/>
<person name="Kohlschutter A."/>
</authorList>
<dbReference type="PubMed" id="12376936"/>
<dbReference type="DOI" id="10.1002/ajmg.10660"/>
</citation>
<scope>VARIANTS CLN2 GLN-127; SER-286 AND PRO-353</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2002" name="J. Med. Genet." volume="39" first="822" last="825">
<title>Identification of novel CLN2 mutations shows Canadian specific NCL2 alleles.</title>
<authorList>
<person name="Ju W."/>
<person name="Zhong R."/>
<person name="Moore S."/>
<person name="Moroziewicz D."/>
<person name="Currie J.R."/>
<person name="Parfrey P."/>
<person name="Brown W.T."/>
<person name="Zhong N."/>
</authorList>
<dbReference type="PubMed" id="12414822"/>
<dbReference type="DOI" id="10.1136/jmg.39.11.822"/>
</citation>
<scope>VARIANTS CLN2 MET-277; PRO-278; VAL-284 AND CYS-481</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2002" name="Vopr. Med. Khim." volume="48" first="594" last="598">
<title>Tripeptidyl peptidase 1 deficiency in neuronal ceroid lipofuscinosis. A novel mutation.</title>
<authorList>
<person name="Bukina A.M."/>
<person name="Tsvetkova I.V."/>
<person name="Semiachkina A.N."/>
<person name="Il'ina E.S."/>
</authorList>
<dbReference type="PubMed" id="12698559"/>
</citation>
<scope>VARIANT CLN2 HIS-206</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2004" name="Glycobiology" volume="14" first="1C" last="5C">
<title>Mutation of the glycosylated asparagine residue 286 in human CLN2 protein results in loss of enzymatic activity.</title>
<authorList>
<person name="Tsiakas K."/>
<person name="Steinfeld R."/>
<person name="Storch S."/>
<person name="Ezaki J."/>
<person name="Lukacs Z."/>
<person name="Kominami E."/>
<person name="Kohlschuetter A."/>
<person name="Ullrich K."/>
<person name="Braulke T."/>
</authorList>
<dbReference type="PubMed" id="14736728"/>
<dbReference type="DOI" id="10.1093/glycob/cwh054"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT CLN2 SER-286</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2009" name="Brain" volume="132" first="810" last="819">
<title>Mutations in CLN7/MFSD8 are a common cause of variant late-infantile neuronal ceroid lipofuscinosis.</title>
<authorList>
<person name="Kousi M."/>
<person name="Siintola E."/>
<person name="Dvorakova L."/>
<person name="Vlaskova H."/>
<person name="Turnbull J."/>
<person name="Topcu M."/>
<person name="Yuksel D."/>
<person name="Gokben S."/>
<person name="Minassian B.A."/>
<person name="Elleder M."/>
<person name="Mole S.E."/>
<person name="Lehesjoki A.-E."/>
</authorList>
<dbReference type="PubMed" id="19201763"/>
<dbReference type="DOI" id="10.1093/brain/awn366"/>
</citation>
<scope>VARIANT CLN2 ARG-482</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2010" name="Hum. Mutat." volume="31" first="710" last="721">
<title>Functional consequences and rescue potential of pathogenic missense mutations in tripeptidyl peptidase I.</title>
<authorList>
<person name="Walus M."/>
<person name="Kida E."/>
<person name="Golabek A.A."/>
</authorList>
<dbReference type="PubMed" id="20340139"/>
<dbReference type="DOI" id="10.1002/humu.21251"/>
</citation>
<scope>VARIANT CLN2 SER-544</scope>
<scope>CHARACTERIZATION OF VARIANTS CLN2 ARG-77; GLN-127; LEU-202; CYS-206; MET-277; VAL-284; SER-286; ASN-287; LYS-343; ARG-365; HIS-422; HIS-447; LEU-475 AND SER-544</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2012" name="Epilepsia" volume="53" first="1387" last="1398">
<title>Targeted next generation sequencing as a diagnostic tool in epileptic disorders.</title>
<authorList>
<person name="Lemke J.R."/>
<person name="Riesch E."/>
<person name="Scheurenbrand T."/>
<person name="Schubach M."/>
<person name="Wilhelm C."/>
<person name="Steiner I."/>
<person name="Hansen J."/>
<person name="Courage C."/>
<person name="Gallati S."/>
<person name="Buerki S."/>
<person name="Strozzi S."/>
<person name="Simonetti B.G."/>
<person name="Grunt S."/>
<person name="Steinlin M."/>
<person name="Alber M."/>
<person name="Wolff M."/>
<person name="Klopstock T."/>
<person name="Prott E.C."/>
<person name="Lorenz R."/>
<person name="Spaich C."/>
<person name="Rona S."/>
<person name="Lakshminarasimhan M."/>
<person name="Kroell J."/>
<person name="Dorn T."/>
<person name="Kraemer G."/>
<person name="Synofzik M."/>
<person name="Becker F."/>
<person name="Weber Y.G."/>
<person name="Lerche H."/>
<person name="Boehm D."/>
<person name="Biskup S."/>
</authorList>
<dbReference type="PubMed" id="22612257"/>
<dbReference type="DOI" id="10.1111/j.1528-1167.2012.03516.x"/>
</citation>
<scope>VARIANTS CLN2 ARG-278 AND HIS-422</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2012" name="Hum. Mutat." volume="33" first="42" last="63">
<title>Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses.</title>
<authorList>
<person name="Kousi M."/>
<person name="Lehesjoki A.E."/>
<person name="Mole S.E."/>
</authorList>
<dbReference type="PubMed" id="21990111"/>
<dbReference type="DOI" id="10.1002/humu.21624"/>
</citation>
<scope>VARIANTS CLN2 THR-62; HIS-209; GLN-266; GLN-339; ARG-382; VAL-448; CYS-501; TYR-504 AND ARG-548</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2013" name="Hum. Mutat." volume="34" first="706" last="713">
<title>Autosomal recessive spinocerebellar ataxia 7 (SCAR7) is caused by variants in TPP1, the gene involved in classic late-infantile neuronal ceroid lipofuscinosis 2 disease (CLN2 disease).</title>
<authorList>
<person name="Sun Y."/>
<person name="Almomani R."/>
<person name="Breedveld G.J."/>
<person name="Santen G.W."/>
<person name="Aten E."/>
<person name="Lefeber D.J."/>
<person name="Hoff J.I."/>
<person name="Brusse E."/>
<person name="Verheijen F.W."/>
<person name="Verdijk R.M."/>
<person name="Kriek M."/>
<person name="Oostra B."/>
<person name="Breuning M.H."/>
<person name="Losekoot M."/>
<person name="den Dunnen J.T."/>
<person name="van de Warrenburg B.P."/>
<person name="Maat-Kievit A.J."/>
</authorList>
<dbReference type="PubMed" id="23418007"/>
<dbReference type="DOI" id="10.1002/humu.22292"/>
</citation>
<scope>VARIANT SCAR7 GLY-466</scope>
</reference>
<comment type="function">
<text evidence="6 18 19">Lysosomal serine protease with tripeptidyl-peptidase I activity (PubMed:11054422, PubMed:19038966, PubMed:19038967). May act as a non-specific lysosomal peptidase which generates tripeptides from the breakdown products produced by lysosomal proteinases (PubMed:11054422, PubMed:19038966, PubMed:19038967). Requires substrates with an unsubstituted N-terminus (PubMed:19038966).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="6 18 19">
<text>Release of an N-terminal tripeptide from a polypeptide, but also has endopeptidase activity.</text>
<dbReference type="EC" id="3.4.14.9"/>
</reaction>
</comment>
<comment type="cofactor">
<cofactor evidence="18 19">
<name>Ca(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29108"/>
</cofactor>
<text evidence="18 19">Binds 1 Ca(2+) ion per subunit.</text>
</comment>
<comment type="activity regulation">
<text evidence="6">Inhibited by diisopropyl fluorophosphate (DFP).</text>
</comment>
<comment type="subunit">
<text evidence="17 19 22">Monomer (PubMed:19038967). Interacts with CLN5 (PubMed:19941651). Interacts with CLN3 (PubMed:17237713).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2800203">
<id>O14773</id>
</interactant>
<interactant intactId="EBI-14033503">
<id>E5LBV4</id>
<label>ORF31</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15619703">
<id>O14773-1</id>
</interactant>
<interactant intactId="EBI-15994382">
<id>Q2NKJ3-1</id>
<label>CTC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15619703">
<id>O14773-1</id>
</interactant>
<interactant intactId="EBI-746930">
<id>Q9H668</id>
<label>STN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15619703">
<id>O14773-1</id>
</interactant>
<interactant intactId="EBI-1772203">
<id>O14746</id>
<label>TERT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="22">Lysosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="13">Melanosome</location>
</subcellularLocation>
<text evidence="13">Identified by mass spectrometry in melanosome fractions from stage I to stage IV.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O14773-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O14773-2</id>
<name>2</name>
<sequence type="described" ref="VSP_013118"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Detected in all tissues examined with highest levels in heart and placenta and relatively similar levels in other tissues.</text>
</comment>
<comment type="PTM">
<text evidence="6 18 19">Activated by autocatalytic proteolytical processing upon acidification (PubMed:11054422, PubMed:19038966, PubMed:19038967). N-glycosylation is required for processing and activity (PubMed:19038966, PubMed:19038967).</text>
</comment>
<comment type="disease" evidence="4 5 7 8 10 11 12 14 16 21 23 24 25 27">
<disease id="DI-00811">
<name>Ceroid lipofuscinosis, neuronal, 2</name>
<acronym>CLN2</acronym>
<description>A form of neuronal ceroid lipofuscinosis. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material, and clinically by seizures, dementia, visual loss, and/or cerebral atrophy. The lipopigment pattern seen most often in CLN2 consists of curvilinear profiles.</description>
<dbReference type="MIM" id="204500"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="26">
<disease id="DI-03994">
<name>Spinocerebellar ataxia, autosomal recessive, 7</name>
<acronym>SCAR7</acronym>
<description>A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR7 patients show difficulty walking and writing, dysarthria, limb ataxia, and cerebellar atrophy.</description>
<dbReference type="MIM" id="609270"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="sequence caution" evidence="29">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAM08412" version="1"/>
</conflict>
<text>Incorrectly indicated as originating from bovine.</text>
</comment>
<comment type="sequence caution" evidence="29">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="AAQ88866" version="1"/>
</conflict>
</comment>
<comment type="online information" name="NCL CLN2">
<link uri="https://www.ucl.ac.uk/ncl/cln2.shtml"/>
<text>Neural Ceroid Lipofuscinoses mutation db</text>
</comment>
<comment type="online information" name="Mendelian genes trieptidyl peptidase I (TPP1)">
<link uri="http://www.lovd.nl/TPP1"/>
<text>Leiden Open Variation Database (LOVD)</text>
</comment>
<dbReference type="EC" id="3.4.14.9" evidence="6 18 19"/>
<dbReference type="EMBL" id="AF017456">
<property type="protein sequence ID" value="AAB80725.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF039704">
<property type="protein sequence ID" value="AAC98480.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF491290">
<property type="protein sequence ID" value="AAM08412.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY268890">
<property type="protein sequence ID" value="AAQ72732.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY358502">
<property type="protein sequence ID" value="AAQ88866.1"/>
<property type="status" value="ALT_FRAME"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK222499">
<property type="protein sequence ID" value="BAD96219.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC014863">
<property type="protein sequence ID" value="AAH14863.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS7770.1">
<molecule id="O14773-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000382.3">
<molecule id="O14773-1"/>
<property type="nucleotide sequence ID" value="NM_000391.3"/>
</dbReference>
<dbReference type="PDB" id="1R60">
<property type="method" value="Model"/>
<property type="chains" value="A=196-563"/>
</dbReference>
<dbReference type="PDB" id="3EDY">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=20-563"/>
</dbReference>
<dbReference type="PDB" id="3EE6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A/B=1-563"/>
</dbReference>
<dbReference type="PDBsum" id="1R60"/>
<dbReference type="PDBsum" id="3EDY"/>
<dbReference type="PDBsum" id="3EE6"/>
<dbReference type="SMR" id="O14773"/>
<dbReference type="BioGRID" id="107611">
<property type="interactions" value="76"/>
</dbReference>
<dbReference type="DIP" id="DIP-47434N"/>
<dbReference type="IntAct" id="O14773">
<property type="interactions" value="41"/>
</dbReference>
<dbReference type="MINT" id="O14773"/>
<dbReference type="STRING" id="9606.ENSP00000299427"/>
<dbReference type="MEROPS" id="S53.003"/>
<dbReference type="GlyConnect" id="1858">
<property type="glycosylation" value="8 N-Linked glycans (3 sites)"/>
</dbReference>
<dbReference type="GlyGen" id="O14773">
<property type="glycosylation" value="6 sites, 1 N-linked glycan (1 site)"/>
</dbReference>
<dbReference type="iPTMnet" id="O14773"/>
<dbReference type="PhosphoSitePlus" id="O14773"/>
<dbReference type="BioMuta" id="TPP1"/>
<dbReference type="EPD" id="O14773"/>
<dbReference type="jPOST" id="O14773"/>
<dbReference type="MassIVE" id="O14773"/>
<dbReference type="MaxQB" id="O14773"/>
<dbReference type="PaxDb" id="O14773"/>
<dbReference type="PeptideAtlas" id="O14773"/>
<dbReference type="PRIDE" id="O14773"/>
<dbReference type="ProteomicsDB" id="48224">
<molecule id="O14773-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="48225">
<molecule id="O14773-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="23932">
<property type="antibodies" value="410 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="1200"/>
<dbReference type="Ensembl" id="ENST00000299427">
<molecule id="O14773-1"/>
<property type="protein sequence ID" value="ENSP00000299427"/>
<property type="gene ID" value="ENSG00000166340"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000533371">
<molecule id="O14773-2"/>
<property type="protein sequence ID" value="ENSP00000437066"/>
<property type="gene ID" value="ENSG00000166340"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000642892">
<molecule id="O14773-2"/>
<property type="protein sequence ID" value="ENSP00000494165"/>
<property type="gene ID" value="ENSG00000166340"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000645620">
<molecule id="O14773-2"/>
<property type="protein sequence ID" value="ENSP00000493657"/>
<property type="gene ID" value="ENSG00000166340"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000647152">
<molecule id="O14773-2"/>
<property type="protein sequence ID" value="ENSP00000495893"/>
<property type="gene ID" value="ENSG00000166340"/>
</dbReference>
<dbReference type="GeneID" id="1200"/>
<dbReference type="KEGG" id="hsa:1200"/>
<dbReference type="UCSC" id="uc001mek.2">
<molecule id="O14773-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1200"/>
<dbReference type="DisGeNET" id="1200"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000166340.14"/>
<dbReference type="GeneCards" id="TPP1"/>
<dbReference type="GeneReviews" id="TPP1"/>
<dbReference type="HGNC" id="HGNC:2073">
<property type="gene designation" value="TPP1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000166340">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="TPP1"/>
<dbReference type="MIM" id="204500">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="607998">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="609270">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O14773"/>
<dbReference type="OpenTargets" id="ENSG00000166340"/>
<dbReference type="Orphanet" id="284324">
<property type="disease" value="Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia"/>
</dbReference>
<dbReference type="Orphanet" id="228349">
<property type="disease" value="CLN2 disease"/>
</dbReference>
<dbReference type="PharmGKB" id="PA26600"/>
<dbReference type="eggNOG" id="ENOG502QR6D">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000008684"/>
<dbReference type="HOGENOM" id="HOG000171253"/>
<dbReference type="InParanoid" id="O14773"/>
<dbReference type="KO" id="K01279"/>
<dbReference type="OMA" id="GCRHLGK"/>
<dbReference type="OrthoDB" id="1294880at2759"/>
<dbReference type="PhylomeDB" id="O14773"/>
<dbReference type="TreeFam" id="TF333497"/>
<dbReference type="BRENDA" id="3.4.14.9">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="O14773"/>
<dbReference type="Reactome" id="R-HSA-381038">
<property type="pathway name" value="XBP1(S) activates chaperone genes"/>
</dbReference>
<dbReference type="SABIO-RK" id="O14773"/>
<dbReference type="SignaLink" id="O14773"/>
<dbReference type="BioGRID-ORCS" id="1200">
<property type="hits" value="5 hits in 875 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="TPP1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="O14773"/>
<dbReference type="GeneWiki" id="Tripeptidyl_peptidase_I"/>
<dbReference type="GenomeRNAi" id="1200"/>
<dbReference type="Pharos" id="O14773">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:O14773"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 11"/>
</dbReference>
<dbReference type="RNAct" id="O14773">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000166340">
<property type="expression patterns" value="Expressed in right adrenal gland cortex and 225 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="O14773">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O14773">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043202">
<property type="term" value="C:lysosomal lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005764">
<property type="term" value="C:lysosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042470">
<property type="term" value="C:melanosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0055037">
<property type="term" value="C:recycling endosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004175">
<property type="term" value="F:endopeptidase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035727">
<property type="term" value="F:lysophosphatidic acid binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0008233">
<property type="term" value="F:peptidase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042277">
<property type="term" value="F:peptide binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004252">
<property type="term" value="F:serine-type endopeptidase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0008236">
<property type="term" value="F:serine-type peptidase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0120146">
<property type="term" value="F:sulfatide binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008240">
<property type="term" value="F:tripeptidyl-peptidase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045453">
<property type="term" value="P:bone resorption"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007417">
<property type="term" value="P:central nervous system development"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030855">
<property type="term" value="P:epithelial cell differentiation"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036498">
<property type="term" value="P:IRE1-mediated unfolded protein response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006629">
<property type="term" value="P:lipid metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007040">
<property type="term" value="P:lysosome organization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007399">
<property type="term" value="P:nervous system development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050885">
<property type="term" value="P:neuromuscular process controlling balance"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043171">
<property type="term" value="P:peptide catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030163">
<property type="term" value="P:protein catabolic process"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070198">
<property type="term" value="P:protein localization to chromosome, telomeric region"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0006508">
<property type="term" value="P:proteolysis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd04056">
<property type="entry name" value="Peptidases_S53"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd11377">
<property type="entry name" value="Pro-peptidase_S53"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.200">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000209">
<property type="entry name" value="Peptidase_S8/S53_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036852">
<property type="entry name" value="Peptidase_S8/S53_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR015366">
<property type="entry name" value="S53_propep"/>
</dbReference>
<dbReference type="InterPro" id="IPR030400">
<property type="entry name" value="Sedolisin_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF00082">
<property type="entry name" value="Peptidase_S8"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF09286">
<property type="entry name" value="Pro-kuma_activ"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00944">
<property type="entry name" value="Pro-kuma_activ"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52743">
<property type="entry name" value="SSF52743"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51695">
<property type="entry name" value="SEDOLISIN"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0068">Autocatalytic cleavage</keyword>
<keyword id="KW-0106">Calcium</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0887">Epilepsy</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0458">Lysosome</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0525">Neuronal ceroid lipofuscinosis</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0645">Protease</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0720">Serine protease</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0950">Spinocerebellar ataxia</keyword>
<keyword id="KW-0865">Zymogen</keyword>
<feature type="signal peptide" evidence="6">
<location>
<begin position="1"/>
<end position="19"/>
</location>
</feature>
<feature type="propeptide" description="Removed in mature form" id="PRO_0000027374" evidence="3 6">
<location>
<begin position="20"/>
<end position="195"/>
</location>
</feature>
<feature type="chain" description="Tripeptidyl-peptidase 1" id="PRO_0000027375">
<location>
<begin position="196"/>
<end position="563"/>
</location>
</feature>
<feature type="domain" description="Peptidase S53">
<location>
<begin position="199"/>
<end position="563"/>
</location>
</feature>
<feature type="active site" description="Charge relay system" evidence="18 19">
<location>
<position position="272"/>
</location>
</feature>
<feature type="active site" description="Charge relay system" evidence="18 19">
<location>
<position position="276"/>
</location>
</feature>
<feature type="active site" description="Charge relay system" evidence="18 19 30">
<location>
<position position="475"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="18 19">
<location>
<position position="517"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium; via carbonyl oxygen" evidence="18 19">
<location>
<position position="518"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium; via carbonyl oxygen" evidence="18 19">
<location>
<position position="539"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium; via carbonyl oxygen" evidence="18 19">
<location>
<position position="541"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="18 19">
<location>
<position position="543"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="18 19 20">
<location>
<position position="210"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="20">
<location>
<position position="222"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="18 19">
<location>
<position position="286"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="18 19 20">
<location>
<position position="313"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="15 18 19 20">
<location>
<position position="443"/>
</location>
</feature>
<feature type="disulfide bond" evidence="18 19">
<location>
<begin position="111"/>
<end position="122"/>
</location>
</feature>
<feature type="disulfide bond" evidence="18 19">
<location>
<begin position="365"/>
<end position="526"/>
</location>
</feature>
<feature type="disulfide bond" evidence="18 19">
<location>
<begin position="522"/>
<end position="537"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_013118" evidence="28">
<location>
<begin position="1"/>
<end position="243"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2734715." id="VAR_037572">
<original>S</original>
<variation>L</variation>
<location>
<position position="62"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2." id="VAR_066883" evidence="24">
<original>S</original>
<variation>T</variation>
<location>
<position position="62"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; displays very low residual enzyme activity; altered intracellular trafficking; dbSNP:rs121908195." id="VAR_009603" evidence="4 23">
<original>G</original>
<variation>R</variation>
<location>
<position position="77"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1800746." id="VAR_009604" evidence="4 9">
<original>Q</original>
<variation>R</variation>
<location>
<position position="100"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; displays residual enzyme activity; effectively transported to the lysosome; dbSNP:rs121908204." id="VAR_016790" evidence="8 11 23">
<original>R</original>
<variation>Q</variation>
<location>
<position position="127"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; dbSNP:rs1554902028." id="VAR_016791">
<original>S</original>
<variation>P</variation>
<location>
<position position="153"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs764922748." id="VAR_005642" evidence="27">
<original>R</original>
<variation>H</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34758634." id="VAR_037573">
<original>R</original>
<variation>C</variation>
<location>
<position position="185"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; displays no residual enzyme activity; altered intracellular trafficking; dbSNP:rs121908205." id="VAR_063640" evidence="10 23">
<original>P</original>
<variation>L</variation>
<location>
<position position="202"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; displays no residual enzyme activity; altered intracellular trafficking; dbSNP:rs28940573." id="VAR_009605" evidence="5 23">
<original>R</original>
<variation>C</variation>
<location>
<position position="206"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; dbSNP:rs121908209." id="VAR_016792" evidence="14">
<original>R</original>
<variation>H</variation>
<location>
<position position="206"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; dbSNP:rs1218678626." id="VAR_066884" evidence="24">
<original>Y</original>
<variation>H</variation>
<location>
<position position="209"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; dbSNP:rs757953998." id="VAR_066885" evidence="24">
<original>R</original>
<variation>Q</variation>
<location>
<position position="266"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; displays no residual enzyme activity; altered intracellular trafficking; demonstrates enhanced processing in response to folding improvement treatment; dbSNP:rs121908207." id="VAR_016793" evidence="12 23">
<original>V</original>
<variation>M</variation>
<location>
<position position="277"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; dbSNP:rs796053439." id="VAR_016794" evidence="12">
<original>Q</original>
<variation>P</variation>
<location>
<position position="278"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; dbSNP:rs796053439." id="VAR_072749" evidence="25">
<original>Q</original>
<variation>R</variation>
<location>
<position position="278"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; displays no residual enzyme activity; altered intracellular trafficking; dbSNP:rs119455957." id="VAR_016795" evidence="8 12 23">
<original>G</original>
<variation>V</variation>
<location>
<position position="284"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; enzymatically inactive; lacks one oligosaccharide chain resulting in enzymatic inactivation and possibly prelysosomal protein degradation; altered intracellular trafficking; dbSNP:rs119455958." id="VAR_016796" evidence="11 16 23">
<original>N</original>
<variation>S</variation>
<location>
<position position="286"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; displays no residual enzyme activity; altered intracellular trafficking; dbSNP:rs121908196." id="VAR_009606" evidence="4 23">
<original>I</original>
<variation>N</variation>
<location>
<position position="287"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; dbSNP:rs765380155." id="VAR_066886" evidence="24">
<original>R</original>
<variation>Q</variation>
<location>
<position position="339"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; displays no residual enzyme activity; altered intracellular trafficking; dbSNP:rs121908197." id="VAR_009607" evidence="4 23">
<original>E</original>
<variation>K</variation>
<location>
<position position="343"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; dbSNP:rs121908206." id="VAR_016797" evidence="11">
<original>T</original>
<variation>P</variation>
<location>
<position position="353"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; displays no residual enzyme activity; altered intracellular trafficking; dbSNP:rs119455953." id="VAR_005643" evidence="4 23 27">
<original>C</original>
<variation>R</variation>
<location>
<position position="365"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; dbSNP:rs119455954." id="VAR_005644" evidence="4 27">
<original>C</original>
<variation>Y</variation>
<location>
<position position="365"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2." id="VAR_066887" evidence="24">
<original>S</original>
<variation>R</variation>
<location>
<position position="382"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; dbSNP:rs121908198." id="VAR_009608" evidence="4">
<original>V</original>
<variation>D</variation>
<location>
<position position="385"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; dbSNP:rs121908199." id="VAR_009609" evidence="4 9">
<original>G</original>
<variation>E</variation>
<location>
<position position="389"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; displays no residual enzyme activity; altered intracellular trafficking;; dbSNP:rs121908200." id="VAR_009610" evidence="4 23 25">
<original>Q</original>
<variation>H</variation>
<location>
<position position="422"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2." id="VAR_016798" evidence="8">
<original>K</original>
<variation>N</variation>
<location>
<position position="428"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; displays very low residual enzyme activity; altered intracellular trafficking; demonstrates enhanced processing in response to folding improvement treatment; shows a five fold increase under permissive temperature conditions; dbSNP:rs119455956." id="VAR_005645" evidence="4 9 23">
<original>R</original>
<variation>H</variation>
<location>
<position position="447"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2." id="VAR_066888" evidence="24">
<original>A</original>
<variation>V</variation>
<location>
<position position="448"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; dbSNP:rs121908201." id="VAR_009611" evidence="4">
<original>A</original>
<variation>E</variation>
<location>
<position position="454"/>
</location>
</feature>
<feature type="sequence variant" description="In SCAR7; dbSNP:rs398122959." id="VAR_070917" evidence="26">
<original>V</original>
<variation>G</variation>
<location>
<position position="466"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; dbSNP:rs121908203." id="VAR_016799" evidence="7 8">
<original>G</original>
<variation>R</variation>
<location>
<position position="473"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; displays no residual enzyme activity; effectively transported to the lysosome; dbSNP:rs121908202." id="VAR_009612" evidence="4 23">
<original>S</original>
<variation>L</variation>
<location>
<position position="475"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2." id="VAR_016800" evidence="12">
<original>F</original>
<variation>C</variation>
<location>
<position position="481"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; dbSNP:rs121908208." id="VAR_058435" evidence="21">
<original>G</original>
<variation>R</variation>
<location>
<position position="482"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2." id="VAR_066889" evidence="24">
<original>G</original>
<variation>C</variation>
<location>
<position position="501"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2." id="VAR_066890" evidence="24">
<original>N</original>
<variation>Y</variation>
<location>
<position position="504"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; displays residual enzyme activity; effectively transported to the lysosome; dbSNP:rs121908210." id="VAR_063641" evidence="23">
<original>P</original>
<variation>S</variation>
<location>
<position position="544"/>
</location>
</feature>
<feature type="sequence variant" description="In CLN2; dbSNP:rs1348967263." id="VAR_066891" evidence="24">
<original>W</original>
<variation>R</variation>
<location>
<position position="548"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="6">
<original>H</original>
<variation>A</variation>
<location>
<position position="236"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inactive. Impaired processing." evidence="6">
<original>D</original>
<variation>A</variation>
<location>
<position position="360"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inactive. Impaired processing." evidence="6">
<original>S</original>
<variation>A</variation>
<location>
<position position="475"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inactive. Impaired processing." evidence="6">
<original>D</original>
<variation>A</variation>
<location>
<position position="517"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; BAD96219." ref="6" evidence="29">
<original>I</original>
<variation>N</variation>
<location>
<position position="115"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; AAH14863." ref="7" evidence="29">
<original>Q</original>
<variation>E</variation>
<location>
<position position="373"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="35"/>
<end position="40"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="46"/>
<end position="53"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="58"/>
<end position="69"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="74"/>
<end position="77"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="82"/>
<end position="89"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="93"/>
<end position="106"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="109"/>
<end position="113"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="119"/>
<end position="125"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="126"/>
<end position="132"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="139"/>
<end position="143"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="144"/>
<end position="147"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="148"/>
<end position="152"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="161"/>
<end position="163"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="164"/>
<end position="166"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="167"/>
<end position="170"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="202"/>
<end position="208"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="219"/>
<end position="221"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="224"/>
<end position="229"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="237"/>
<end position="247"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="258"/>
<end position="262"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="271"/>
<end position="283"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="284"/>
<end position="286"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="287"/>
<end position="292"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="295"/>
<end position="300"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="303"/>
<end position="311"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="319"/>
<end position="324"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="329"/>
<end position="331"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="334"/>
<end position="349"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="353"/>
<end position="357"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="366"/>
<end position="368"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="371"/>
<end position="373"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="379"/>
<end position="381"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="385"/>
<end position="397"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="402"/>
<end position="404"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="411"/>
<end position="417"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="420"/>
<end position="422"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="423"/>
<end position="432"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="439"/>
<end position="441"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="446"/>
<end position="449"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="451"/>
<end position="455"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="457"/>
<end position="463"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="466"/>
<end position="471"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="474"/>
<end position="494"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="504"/>
<end position="509"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="510"/>
<end position="514"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="522"/>
<end position="525"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="529"/>
<end position="533"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="534"/>
<end position="537"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="544"/>
<end position="546"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="553"/>
<end position="558"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3EDY"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3EE6"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25944712"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10330339"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10665500"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11054422"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11241479"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11339651"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11462245"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11589012"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12376936"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12414822"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12643545"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12698559"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12754519"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14736728"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17237713"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19038966"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19038967"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19201763"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19941651"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20340139"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21990111"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22612257"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23418007"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9295267"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000303">
<source ref="4"/>
</evidence>
<evidence key="29" type="ECO:0000305"/>
<evidence key="30" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="11054422"/>
</source>
</evidence>
<sequence length="563" mass="61248" checksum="7299D902F6AE8555" modified="2006-05-30" version="2" precursor="true">MGLQACLLGLFALILSGKCSYSPEPDQRRTLPPGWVSLGRADPEEELSLTFALRQQNVERLSELVQAVSDPSSPQYGKYLTLENVADLVRPSPLTLHTVQKWLLAAGAQKCHSVITQDFLTCWLSIRQAELLLPGAEFHHYVGGPTETHVVRSPHPYQLPQALAPHVDFVGGLHRFPPTSSLRQRPEPQVTGTVGLHLGVTPSVIRKRYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMRLFGGNFAHQASVARVVGQQGRGRAGIEASLDVQYLMSAGANISTWVYSSPGRHEGQEPFLQWLMLLSNESALPHVHTVSYGDDEDSLSSAYIQRVNTELMKAAARGLTLLFASGDSGAGCWSVSGRHQFRPTFPASSPYVTTVGGTSFQEPFLITNEIVDYISGGGFSNVFPRPSYQEEAVTKFLSSSPHLPPSSYFNASGRAYPDVAALSDGYWVVSNRVPIPWVSGTSASTPVFGGILSLINEHRILSGRPPLGFLNPRLYQQHGAGLFDVTRGCHESCLDEEVEGQGFCSGPGWDPVTGWGTPNFPALLKTLLNP</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

